Search results
Emcure Pharma IPO: Issue fully subscribed on day 1; check subscription status, GMP and other details...
Livemint· 5 days agoBefore the issue opened, the company secured ₹582 crore from anchor investors. Notable participants...
Emcure Pharmaceuticals IPO: 10 key risks investors should consider before subscribing to the...
Livemint· 5 days agoEmcure Pharmaceuticals IPO sails through first day of bidding smoothly led by non institutional and...
Bansal Wire IPO gets fully subscribed on first day; Read key details here before you subscribe
Financial Express· 5 days agoThe company will use the raised proceeds for repayment of outstanding borrowings, working capital...
Namita Thapar-backed Emcure Pharma IPO kicks off: Should you subscribe to the issue?
Business Today· 5 days agoThe Shark Tank India fame Namita Thapar-backed company is offering its shares in the range of Rs...
Emcure Pharmaceuticals IPO: Check subscription on Day 1, GMP and other details - The Economic Times
The Economic Times· 5 days agoThe initial public offer (IPO) of Emcure Pharmaceuticals, which opened earlier today, was booked 66%...
Emcure Pharma opens for subscription today: Should you subscribe? Know all about it here | Business...
Business Insider India· 5 days agoThe company aims to raise Rs 800 crore via fresh issue of 0.79 crore shares and Rs 1,152.03 crore...
Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other details
The Economic Times· 5 days agoThe initial public offer (IPO) of Emcure Pharmaceuticals, which opened earlier today, was booked...
Who Is Namita Thapar, Shark Tank Judge Set To Earn Rs 127 Crore From IPO
NDTV· 5 days agoEntrepreneur Namita Thapar is set to reap a remarkable 293x return on her initial investment in...
Shark Tank Judge Namita Thapar To Earn Rs 127 Crore From Emcure IPO
NDTV· 5 days agoNamita Thapar, the Executive Director of Emcure Pharmaceuticals, is set to earn approximately Rs...
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid? - The Economic Times
The Economic Times· 5 days agoEmcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity...